| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 1 | +6.81K | 42.6% | $0.73 | +$4.97K |
| Sells | 2 | -9.18K | 57.4% | $0.56 | -$5.14K |
| Net | -1 | -2.37K | -14.8% | -$170 |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Takeda Pharmaceutical Co Ltd | 10%+ Owner | $16.2M | Jul 1, 2022 | ||
| Jeremy M. Levin | CEO, Director | $10.1M | Feb 20, 2025 | ||
| Amit Rakhit | President and CMO | $1.56M | Jul 14, 2021 | ||
| Stelios Papadopoulos | Director | $112K | Mar 3, 2025 | ||
| Thomas M. Perone | General Counsel, Secretary | $60.5K | Feb 22, 2024 | ||
| Jason Tardio | Chief Operating Officer | $60.5K | Feb 22, 2024 | ||
| Margaret A. Alexander | President and COO | $41.1K | +$2.02K | +5.15% | Feb 26, 2025 |
| Jeffrey A. Rona | Cbfo | $38.1K | -$2.19K | -5.43% | Feb 26, 2025 |
| Douglas E. Williams | Director | May 17, 2021 | |||
| Bart Friedman | Director | Feb 20, 2025 | |||
| Barbara Gayle Duncan | Director | Feb 20, 2025 | |||
| Karen Bernstein | Director | Feb 20, 2025 | |||
| Kevin Fitzgerald | Director | Feb 20, 2025 | |||
| Robert Michael Poole | Director | Feb 22, 2024 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|